Testing a new drug for advanced solid tumors
This trial tests an experimental drug, BA1203, for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and whether it can help shrink tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced or metastatic solid tumor that has progressed on all standard treatments, or you cannot tolerate or are not eligible for standard treatments.
- You have at least one measurable tumor (as assessed by scans).
- If you have colorectal cancer, you need a microsatellite instability (MSI) test report. For other tumor types, a PD-L1 test report is needed, or you must provide a tissue sample for testing.
- You are expected to live at least 12 more weeks.
- You are physically active enough to do light activities (ECOG performance status 0 or 1).
- Your major organs (like heart, liver, kidneys) are functioning well enough.
- If you can have children, you agree to use effective birth control during the trial.
- You do not have untreated or symptomatic brain metastases.
- You have not had certain severe lung, digestive, or bleeding conditions in the past 8 weeks.
- You have not had an allergic reaction like Stevens-Johnson syndrome to previous treatments.
- You have not taken PD-1/IL-2 or PD-1/IL-15 drugs before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called BA1106 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe, tolerable, and whether it can help shrink tumors.
This trial tests an experimental drug called Hemay5087 for people with advanced solid tumors. It aims to find out if the drug is safe and how well it works, offering a possible option when standard treatments have failed.
This Phase 1 study tests BA1202 in people with advanced solid cancers to find safe dosing and how the treatment may work. You may qualify if your cancer has progressed or you cannot use standard treatment, and—depending on the group—your tumor shows a specific marker called CEACAM5.
This trial tests an experimental drug for people with advanced solid tumors, including small cell lung cancer, that have stopped responding to standard treatments. The goal is to find out if the drug is safe and effective.
This study tests a new drug (BB-1709) for people with advanced solid tumors that haven't responded to standard treatments. The goal is to see if it's safe and how well it works.
This study tests a new drug called BI 3822971 for people with advanced cancer that has not responded to standard treatments. The goal is to find the best dose that is safe and well-tolerated.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.